98%
921
2 minutes
20
The synthesis of gold nanoparticles (AuNPs) green methods is advantageous due to their economic viability, reduced environmental pollution, and safety towards human health. According to our best knowledge, there is limited documented research on synthesizing AuNPs using gum Arabic (GA) and cinnamon (CNM) and studying their anticancer activities against colorectal cancer cells. This study presents a simple approach to synthesizing AuNPs using GA and CNM, characterized by advanced analytical techniques, including UV-Vis and FTIR spectroscopies, SEM, EDS, TEM, SAED, Zeta sizer, and Zeta potential. The absorption spectra displayed characteristic bands between 520-530 nm, confirming the successful synthesis of AuNPs. TEM analysis revealed that AuNPs@GA exhibited a spherical shape, while AuNPs@CNM displayed diverse morphologies (, spherical, hexagonal, and diamond shapes) with average sizes of approximately 12 nm and 17 nm, respectively. SEM/EDS data confirmed the presence of AuNPs alongside organic compounds such as carbon, oxygen, and phosphorus. The cytotoxic effects of these AuNPs were evaluated on colorectal cancer cells (HCT-116) and healthy cells (HEK-293) using an MTT assay. Notably, AuNPs@GA resulted in a 43.61% loss in cell viability at the dose of 5 μg mL, while AuNPs@CNM led to an impressive 80.33% loss. The calculated IC values were 9.14 μg mL for AuNPs@GA and 11.76 μg mL for AuNPs@CNM, highlighting the potential of these AuNPs as effective agents in colon cancer treatment. This study not only addresses the lack of research on GA and CNM in NP synthesis but also demonstrates their promising anticancer properties, paving the way for further exploration in cancer therapeutics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565694 | PMC |
http://dx.doi.org/10.1039/d4ra06340f | DOI Listing |
Cancer Epidemiol Biomarkers Prev
September 2025
Brigham and Women's Hospital, Boston, MA, United States.
Background: Colorectal cancer (CRC) risk models routinely adjust for endoscopic screening because of a) possible confounding with other risk factors and b) possible alteration of natural history of the disease due to adenoma detection and removal.
Methods: In this study, we defined a subject as screen-covered (SC) if a colonoscopy was performed in the past 10 years, and not screen-covered (NSC) otherwise. We created CRC risk models separately for SC and NSC subjects (HRSC, HRNSC) and then obtained a screening-coverage adjusted HR estimate (HRfull) based on a weighted average of ln(HRSC) and ln(HRNSC) with weight equal to the proportion of SC person-time in the NHS population.
JACC Case Rep
September 2025
Department of Cardiovascular Surgery, Nagoya Heart Center, Nagoya, Japan.
Background: Capecitabine, an oral prodrug of 5-fluorouracil, is widely used for gastrointestinal malignancies. While its coronary toxicity is well documented, large-vessel complications such as aortic dissection are rarely reported.
Case Summary: We present a 65-year-old man with colorectal cancer who developed Stanford type A aortic dissection 3 days after initiating adjuvant capecitabine therapy.
Br J Surg
September 2025
Department of Digestive Surgery, CARPEM Comprehensive Cancer Centre, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France.
Rep Pract Oncol Radiother
August 2025
Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland.
Background: The rising burden of colorectal cancer with a high prevalence of advanced stages of new-onset is reported worldwide. While applied, chemotherapy can extend patients' survival, and proper tailoring is paramount. Based on computed tomography results, the study aimed to point out potential prognostic factors of complete or partial response to the initial three months of chemotherapy in palliative colorectal (CRC) cancer.
View Article and Find Full Text PDFFront Chem
August 2025
Guangzhou Key Laboratory of Formula-Pattern Research Center, School of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People's Hospital), Jinan University, Guangzhou, China.
Introduction: Colorectal cancer (CRC) is a prevalent malignant tumor of the digestive tract. The FOLFOX regimen (oxaliplatin + calcium folinate + 5-fluorouracil) serves as the primary treatment for advanced CRC clinically, yet its application is significantly limited by substantial toxic side effects. Erianin, a natural compound from Chinese medicine Lindl, demonstrates significant potential in both tumor growth inhibition and chemotherapy toxicity reduction.
View Article and Find Full Text PDF